Andreas Trojan
- Oncology top 5%
- HER2/EGFR in Cancer Research 10
- Cancer Treatment and Pharmacology 10
- Cancer survivorship and care 6
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 8
- Genetics top 5%
- Hematology top 5%
- Biomaterials top 10%
-
- Breast Cancer Treatment Studies 6
-
- vaccines and immunoinformatics approaches 5
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Anand RajeswaranBernard BurnandMathias Witzens‐HarigJohn G. GribbenRolf A. StahelMirjana UrosevicReinhard DummerJohn W. Donovan
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Andreas Trojan
62 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Oncology 741
- Immunology 567
- Genetics 206
- Hematology 151
- Biomaterials 156
Countries citing papers authored by Andreas Trojan
This map shows the geographic impact of Andreas Trojan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Trojan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Trojan more than expected).
Fields of papers citing papers by Andreas Trojan
This network shows the impact of papers produced by Andreas Trojan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Trojan. The network helps show where Andreas Trojan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Trojan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 12 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 8 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 1 | |
| 9 | 2016 | 73 | |
| 10 | 2013 | 25 | |
| 11 | 2013 | 47 | |
| 12 | 2012 | 5 | |
| 13 | 2012 | 17 | |
| 14 | 2007 | 176 | |
| 15 | 2004 | 41 | |
| 16 | 2002 | 17 | |
| 17 | 2002 | 54 | |
| 18 | 2001 | 21 | |
| 19 | 1998 | 9 | |
| 20 | 1998 | 5 |
About Andreas Trojan
Andreas Trojan is a scholar working on Oncology, Immunology and Genetics, having authored 64 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (10 papers), Immune Cell Function and Interaction (8 papers), Cancer survivorship and care (6 papers), Breast Cancer Treatment Studies (6 papers), vaccines and immunoinformatics approaches (5 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Oncology (741 citations), Immunology (567 citations) and Genetics (206 citations). Andreas Trojan has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Anand Rajeswaran, Bernard Burnand, Mathias Witzens‐Harig, John G. Gribben, Rolf A. Stahel, Mirjana Urosevic, Reinhard Dummer, John W. Donovan, Marco Ladetto and Joachim L. Schultze. Their work appears in journals such as Lung Cancer, Breast Care, PLoS ONE, Blood and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.